Elsevier Welcomes New Editor-in-Chief for European Urology

          Elsevier Welcomes New Editor-in-Chief for European Urology

  PR Newswire

  AMSTERDAM, The Netherlands, January 28, 2013

AMSTERDAM, The Netherlands, January 28, 2013 /PRNewswire/ --

Elsevier , a world-leading provider of scientific, technical and medical
information products and services, welcomes Dr. James Catto, MB ChB, PhD, FRCS
(Urol), of the Academic Urology Unit, Royal Hallamshire Hospital in Sheffield
(UK) as the new Editor-in-Chief of European Urology , the official journal of
the European Association of Urology (EAU).

The journal has been a prestigious urological forum for over35 years, and is
currently read by more than 20,000 urologists across the globe. With an impact
factor of 8.493, European Urology is now the leading scientific publication in
the field of urology. Dr. Catto will replace Professor Montorsi effective
January 1, 2014.

In his new role, Dr. Catto aims to strengthen the journal's success and
envisions European Urology as a high quality and high impact journal which is
supported by a robust multimedia platform and a user-friendly interface.

"We will expand into social media platforms and create a more interactive user
experience. I will try to broaden our appeal to other professionals, butat
our corewe will remain a high quality urological journal that serves and
highly values its readers and authors," explained Dr. Catto. " European
Urology greatly contributes to the mission of the EAU - improving the care for
patients with urological disease - and this is a tremendous motivation for me.
As Editor-in-Chief, I will be able to focus the minds of our readership upon
crucial clinical issues, whilst driving forward change and innovation. I aim
to keep urologists at the forefront of clinical developments and make them key
to high quality patient care."

"I am thankful to work with the EAU and also very grateful for its support and
input over the last years. I look forward to working with the newly appointed
Editor-in-Chief, Dr. James Catto and his editorial team. The management and
cure of for instance prostate cancer as well as the advanced search for the
basic mechanisms of urologic diseases are major and global challenges of the
21 ^st century. Elsevier is confident to make European Urology a continuing
and growing success for authors, readers and for the EAU," commented Koos
Admiraal MD, Executive Publisher for Elsevier.

About  European Urology European Urology , the official journal of the EAU,
has been a prestigious urological forum for over35 years, and is currently
read by more than 20,000 urologists across the globe. With an impact factor of
8.493, the journal is now the leading scientific publication in the field of
urology. For more information, go to: http://www.europeanurology.com

About the European Association of Urology The European Association of Urology
(EAU) is a non-profit organisation which supports medical professionals
working in the field of urology through many of its scientific, professional,
educational and awareness-building initiatives. Through its work the EAU aims
to raise the level of urological care in Europe. For more information about
the EAU, go to: http://www.uroweb.org

About Elsevier Elsevier is a world-leading provider of scientific, technical
and medical information products and services. The company works in
partnership with the global science and health communities to publish more
than 2,000 journals, including The Lancet and Cell , and close to 20,000 book
titles, including major reference works from Mosby and Saunders. Elsevier's
online solutions include ScienceDirect , Scopus , Reaxys , ClinicalKey and
Mosby's Nursing Suite , which enhance the productivity of science and health
professionals, and the SciVal suite and MEDai's Pinpoint Review , which help
research and health care institutions deliver better outcomes more
cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people
worldwide. The company is part of Reed Elsevier Group PLC , a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL
(London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact Carolien van der Zanden Elsevier +31-20-485-3346
c.zanden@elsevier.com
 
Press spacebar to pause and continue. Press esc to stop.